Daria Latysheva

Ms. Latysheva’s experience includes advising:

Equity Capital Markets 

• Cipher Mining Inc. in a US$250 million ATM offering of its common stock
• Cipher Mining Technologies Inc. on its US$2 billion de-SPAC with Good Works Acquisition Corp.
• ABB Ltd on the spin-off and the SIX Swiss Exchange listing of Accelleron Industries AG
• trivago N.V. on the ratio change under its American Depositary Share program
• 10X Capital Venture Acquisition Corp. II on its de-SPAC with African Agriculture Inc.
• Cian PLC on its initial public offering of 18 million American Depositary Shares and listing on the New York Stock Exchange
• Jefferies International Limited and Panmure Gordon (UK) Limited, as joint global coordinators, on the US$1.1 billion initial public offering and listing on the London Stock Exchange of Conduit Holdings Limited*  
• Mail.ru Group Limited on its US$200 million equity placing and its US$400 million convertible bond offering* 
• Goldman Sachs International and Liberum Capital Limited, as joint bookrunners, in connection with the £105 million capital raising of Ted Baker plc by way of a firm placing, placing and open offer and offer for subscription* 
• Credit Suisse Securities (Europe) Limited, as listing agent, in connection with the Frankfurt Stock Exchange listing of Linde plc, the combined company following the merger of Linde AG (Germany) and Praxair, Inc. (US)*
• Goldman Sachs International and UBS Limited, as joint global coordinators, on the re-IPO of Van Lanschot N.V., listed on the Euronext Amsterdam*
• Bank of America and UBS Limited, as joint global coordinators, in connection with the CHF865 million accelerated bookbuild placing and the CHF2.3 billion discounted rights offering by Lonza Group AG (Switzerland) to finance its CHF5.5 billion acquisition of Capsugel S.A. (US)*
• Jefferies and Credit Suisse, as joint global coordinators, on the CHF176 million spin-off by way of an initial public offering and listing on the SIX Swiss Exchange of
• Cassiopea S.p.A., a dermatology division of Cosmo Pharmaceuticals S.A.* 
• RBC Capital Markets and Bank Degroof Petercam, as joint bookrunners, on the €44 million initial public offering and listing on the Euronext Amsterdam and Euronext Brussels of Curetis N.V., a German medtech company specializing in molecular diagnostic solutions for infectious diseases*
• J.P. Morgan and UBS, as joint bookrunners, on the CHF113 million initial public offering and listing on the SIX Swiss Exchange of Molecular Partners AG, a Swiss-based clinical-stage biopharmaceutical company* 
• XXL ASA, a Nordic sports retailer, on its US$400 million initial public offering and listing on the Oslo Børs*
• Triton funds and Alimak Group AB on the SEK2.2 billion initial public offering and listing on Nasdaq OMX Stockholm of Alimak Group AB*

Debt Capital Markets 

• The underwriters on the US$8 billion US-registered note offering of the State Treasury of the Republic of Poland
• The underwriters in connection with multiple US-registered note offerings totaling over US$22.5 billion by the Asian Infrastructure Investment Bank (AIIB), a multilateral development bank
• Solicitation agent on Ukraine’s US$20 billion debt restructuring and consent solicitations relating to its outstanding Eurobonds and GDP-linked securities
• Swissport Group S.à r.l. on its offering of €410 million 5.25% senior secured notes due 2024, €250 million 9.0% senior notes due 2025 and a €850 million term loan B facility*
• Radisson Hospitality AB on its debut high-yield offering of €250 million 6.875% senior secured notes due 2023*
• Credit Suisse, Sberbank CIB, Société Générale, and VTB Capital on the US$500 million 5.3% notes offering by RUSAL Capital D.A.C., guaranteed by various Russian and Jersey companies of UC RUSAL Group*
• Citigroup, Sberbank CIB, and VTB Capital on the US$500 million 3.95% loan participation notes offering by a finance subsidiary of PJSC PhosAgro*
• Bank of America Merrill Lynch and Credit Suisse in the €4 billion mandatory convertible bond offering by Bayer AG (Germany) to partially finance its acquisition of Monsanto (U.S.) and on Bayer’s Rule 144A placement of notes in an aggregate principal amount of US$7 billion*
• Ovako AB, a large European producer and developer of steel products, on its high-yield offering of €300 million 6.5% senior secured notes*

*Matter handled prior to joining Latham